Cas:351003-13-9 2,7-ditert-butyl-9H-fluorene-9-carboxylic acid manufacturer & supplier

Chemical Name:2,7-ditert-butyl-9H-fluorene-9-carboxylic acid

CAS.NO:351003-13-9

Synonyms:2,7-Di-tert-butylfluorene-9-carboxylic acid

Molecular Formula:C₂₂H₂₆O₂

Molecular Weight:322.44100

HS Code:

Physical and Chemical Properties:

Melting point:185-187ºC(lit.)

Boiling point:421ºC at 760 mmHg

Density:1.096g/cm3

Index of Refraction:1.571

PSA:37.30000

Exact Mass:322.19300

LogP:5.47850

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 2,7-Di-tert-butylfluorene-9-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,7-Di-tert-butylfluorene-9-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,7-Di-tert-butylfluorene-9-carboxylic acid Use and application,2,7-Di-tert-butylfluorene-9-carboxylic acid technical grade,usp/ep/jp grade.

Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia. 2,7-ditert-butyl-9H-fluorene-9-carboxylic acid manufacturer Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it. 2,7-ditert-butyl-9H-fluorene-9-carboxylic acid supplier The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 2,7-ditert-butyl-9H-fluorene-9-carboxylic acid vendor In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. 2,7-ditert-butyl-9H-fluorene-9-carboxylic acid factory In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum.